Introduction
============

High flow nasal (HNF) requires precise control of the fraction of inspired oxygen (FiO~2~) and flow contributed as well as an adequate adjustment of temperature and humidity of the gas provided. There are several equipments for HNF. We evaluated the FiO~2~ and flow supplied with three different systems

Methods
=======

There have been analyzed: (1) \'Oxygen Therapy\' from Dräger Evita-XL®; (2) Fisher & Paykel Airvo® option; and (3) pack of flowmeters Debson®. Measurements were made in the distal part of the circuit that is used in clinical practice. Variables: programmed and measured FiO~2~, programmed and measured flow. We used the Oxygen Monitor Ohmeda 5120® and Flow Meter® Fisher-Porter. Before each measurement we checked and/or calibrated each of them. All measurements were performed at room temperature in the ICU of our hospital (23 to 26º).The data were processed using SPSS v.15.0.1, accepting a significance level of 95%.

Results
=======

\(1\) FiO~2~ variation -0.001 ± 0.09 (-0.01 to 0.002); FiO~2~ percentage variation -0.012 ± 1.88 (-0.27 to 0.25); *r*^2^= 0.999 and *r*= 0.998 (*P*\< 0.000). Flow variation (l/minute) 5.45 ± 3.23 (4.94 to 5.96); flow percentage variation 19.59 ± 11.63 (17.75 to 21.43); *r*= 0. 997 and *r*^2^ = 0.994 (*P*\< 0.000). (2) FiO~2~ variation -0.007 ± 0.26 (-0.011/-0.003); FiO~2~percentage variation -1.4040 ± 4.73 (-2.15 to -0.67); *r*= 0.996 and *r*^2^ = 0.992 (*P*\< 0.000). Flow variation (l/minute) 3.82 ± 3.85 (3.04 to 4.69); flow percentage variation 9.76 ± 8.08 (8.11 to 11.41); *r*= 0.969 and *r*^2^= 0.939 (*P*\< 0.000). (3) FiO~2~ variation -0.005 ± 0.26 (-0001 to 0009); FiO~2~ percentage variation -0.72 ± 5.2 (-1.5 to 0.1); *r*= 0.996 and *r*^2^ = 0.992 (*P*\< 0.000). Flow variation (l/minute) 3.91 ± 1.26 (3.69 to 4.13); flow percentage variation 12.77 ± 5.33 (11.84 to 13.7); *r*= 0.996 and *r*^2^ = 0.992 (*P*\< 0.000). See Figure [1](#F1){ref-type="fig"}.
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Conclusion
==========

The FiO~2~ percentage variation in the Airvo® is higher than the other two devices, with no clinical relevance. The flow percentage variation of Evita XL® is superior to the other two devices; this may have some clinical relevance.
